EN
/
FR
Ethics Portal
Who We Are
Who We Are
About Us
Business Model
Our Strategy 2023-2025
Statutes, By-Laws & Policies
Governance & Team
Annual Reports
Careers & RFPs
Contact Us
What We Do
What We Do
Licensing for Public Health
mRNA Technology Transfer Programme
Disease Areas
Addressing Children’s Needs
Prioritising Medicines for Licensing
Long-Acting Therapeutics
Focus areas
Biotherapeutics
Local and Regional Manufacturing
Pandemic Preparedness and Response
Upstream Access
Technology Transfer
Patent Information Tools
MedsPaL
LAPaL
Progress & Impact
Progress
and Impact
Prioritisation
Agreements with Innovators
Access to Medicines Tracker
Contribution to Universal Health Coverage
Endorsements
Impact
News & Publications
News
& Publications
News, Events & Press Releases
Messages from the Executive Director
MPP in the Media
MPP Publications
Related Publications
Newsletters & Updates
Partners
Partners
Partnering with MPP
Funders
How to Give or Get a Licence
Our Stories
Voices from Friends of MPP
Voices from the Frontline
I am part of the DTG story
#LicensingSavesLives
EN
/
FR
Ethics Portal
news & publications
»
MPP Publications
MPP Prioritisation Reports – Archives
1 July 2020
2024 Prioritisation Report
2023 Prioritisation Report
2022 Prioritisation Report
2021 Prioritisation Report
2020 Prioritisation Report
2019 Prioritisation Report
2018 Prioritisation Report
Annex to the 2018 Prioritisation Report: HIV and HCV pipelines compiled by the MPP
2017 Prioritisation Report: Prioritisation of HIV and Hepatitis C medicines for in-licensing by the Medicines Patent Pool
2015 Prioritisation Report: Antiretroviral priorities of the Medicines Patent Pool – 4th Edition
2013 Prioritisation Report Priority Antiretrovirals for the Medicines Patent Pool – 3rd Edition (December 2013)
2012 Prioritisation Report
2011 Prioritisation Report
Share page:
Contact Us
Science
Related page
Prioritising Medicines for Licensing